Literature DB >> 28650438

Cancer therapy: Neutrophils traffic in cancer nanodrugs.

Satoru Osuka1, Erwin G Van Meir1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28650438     DOI： 10.1038/nnano.2017.82

Source DB:  PubMed          Journal:  Nat Nanotechnol        ISSN： 1748-3387            Impact factor:   39.213


× No keyword cloud information.
  9 in total

Review 1.  Stem cells as therapeutic vehicles for the treatment of high-grade gliomas.

Authors:  Emanuela Binello; Isabelle M Germano
Journal:  Neuro Oncol       Date:  2011-12-13       Impact factor: 12.300

Review 2.  Overcoming therapeutic resistance in glioblastoma: the way forward.

Authors:  Satoru Osuka; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

Review 3.  Neutrophil recruitment and function in health and inflammation.

Authors:  Elzbieta Kolaczkowska; Paul Kubes
Journal:  Nat Rev Immunol       Date:  2013-03       Impact factor: 53.106

4.  Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies.

Authors:  Karen S Aboody; Joseph Najbauer; Marianne Z Metz; Massimo D'Apuzzo; Margarita Gutova; Alexander J Annala; Timothy W Synold; Larry A Couture; Suzette Blanchard; Rex A Moats; Elizabeth Garcia; Soraya Aramburo; Valerie V Valenzuela; Richard T Frank; Michael E Barish; Christine E Brown; Seung U Kim; Behnam Badie; Jana Portnow
Journal:  Sci Transl Med       Date:  2013-05-08       Impact factor: 17.956

Review 5.  Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma.

Authors:  Erwin G Van Meir; Costas G Hadjipanayis; Andrew D Norden; Hui-Kuo Shu; Patrick Y Wen; Jeffrey J Olson
Journal:  CA Cancer J Clin       Date:  2010 May-Jun       Impact factor: 508.702

6.  Origin of the U87MG glioma cell line: Good news and bad news.

Authors:  Marie Allen; Mia Bjerke; Hanna Edlund; Sven Nelander; Bengt Westermark
Journal:  Sci Transl Med       Date:  2016-08-31       Impact factor: 17.956

7.  Neutrophil infiltration into human gliomas.

Authors:  G Fossati; G Ricevuti; S W Edwards; C Walker; A Dalton; M L Rossi
Journal:  Acta Neuropathol       Date:  1999-10       Impact factor: 17.088

8.  Human glioblastoma cells release interleukin 6 in vivo and in vitro.

Authors:  E Van Meir; Y Sawamura; A C Diserens; M F Hamou; N de Tribolet
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

9.  Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis.

Authors:  I Desbaillets; A C Diserens; N Tribolet; M F Hamou; E G Van Meir
Journal:  J Exp Med       Date:  1997-10-20       Impact factor: 14.307
  9 in total
  4 in total

1.  A network-based analysis for mining the risk pathways in glioblastoma.

Authors:  Jing Li; Yujie Xie; Chi Zhang; Jianxiong Wang; Yong Wu; Yuan Yang; Yang Xie; Zhiyu Lv
Journal:  Oncol Lett       Date:  2019-07-09       Impact factor: 2.967

2.  The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo.

Authors:  Juan Li; Runhong Lei; Xin Li; Fengxia Xiong; Quanyang Zhang; Yue Zhou; Shengmei Yang; Yanan Chang; Kui Chen; Weihong Gu; Chongming Wu; Gengmei Xing
Journal:  Part Fibre Toxicol       Date:  2018-01-17       Impact factor: 9.400

Review 3.  Nano-and Micromotors Designed for Cancer Therapy.

Authors:  Luisa Sonntag; Juliane Simmchen; Veronika Magdanz
Journal:  Molecules       Date:  2019-09-19       Impact factor: 4.411

4.  Neutrophil Delivered Hollow Titania Covered Persistent Luminescent Nanosensitizer for Ultrosound Augmented Chemo/Immuno Glioblastoma Therapy.

Authors:  Yujie Li; Xucong Teng; Yongji Wang; Chunrong Yang; Xiuping Yan; Jinghong Li
Journal:  Adv Sci (Weinh)       Date:  2021-07-01       Impact factor: 16.806
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.